You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/64427
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPepato, Maria Teresa-
dc.contributor.authorBrunetti, Iguatemy Lourenço-
dc.contributor.authorLourenzoni, A. O.-
dc.contributor.authorFonseca, Luiz Marcos da-
dc.contributor.authorVendramini, R.-
dc.contributor.authorAccetozi, M.-
dc.date.accessioned2014-05-27T11:17:55Z-
dc.date.accessioned2016-10-25T18:13:14Z-
dc.date.available2014-05-27T11:17:55Z-
dc.date.available2016-10-25T18:13:14Z-
dc.date.issued1993-12-01-
dc.identifier.citationRevista de Ciencias Farmaceuticas, v. 15, p. 85-94.-
dc.identifier.issn0101-3793-
dc.identifier.urihttp://hdl.handle.net/11449/64427-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/64427-
dc.description.abstractA study was carried out, on both sexes, to determine the effects of chlorpropamide (DIABINESE) and glibenclamide (DAONIL) on patients with Type II diabetes using as metabolic parameters the following serum: glucose, amilase, high density lipoprotein cholesterol, free fatty acids. The results indicated that both drugs were potentially similar in relation to glycemia, high density lipoprotein cholesterol, and free fatty acids, in both sexes. Chlorpropamide was significantly more effective in reducing amilase activity in male diabetics than glibenclamide. The above mentioned hypoglycemiants did not reduce glycemia to basic levels in either masculine or feminine groups of diabetics.en
dc.format.extent85-94-
dc.language.isopor-
dc.sourceScopus-
dc.subjectamilase-
dc.subjectchlorpropamide-
dc.subjectfree fatty acids-
dc.subjectglibenclamide-
dc.subjectglycemia-
dc.subjecthigh density lipoprotein cholesterol-
dc.subjectnon insulin dependent diabetics-
dc.subjectamylase-
dc.subjectfatty acid-
dc.subjectglucose-
dc.subjectadult-
dc.subjectaged-
dc.subjectclinical trial-
dc.subjectcontrolled clinical trial-
dc.subjectcontrolled study-
dc.subjectdrug effect-
dc.subjectfemale-
dc.subjecthuman-
dc.subjectmajor clinical study-
dc.subjectmale-
dc.subjectmetabolic parameters-
dc.subjectnon insulin dependent diabetes mellitus-
dc.subjectoral drug administration-
dc.titleCOMPARACAO ENTRE MEDICAMENTOS ORAIS ATRAVES DAS TAXAS SERICAS DE GLICOSE, AMILASE, ACIDOS GRAXOS LIVRES E LIPOPROTEINAS DE ALTA DENSIDADE (HDL-COLESTEROL) NOS DIABETICOS DE AMBOS OS SEXOS, DA REGIAO DE ARARAQUARA, NAO-DEPENDENTES DE INSULINApt
dc.title.alternativeComparison of oral medicaments through serum levels of glucose, amilase, free-fatty acids and high density lipoprotein cholesterol (HDL-cholesterol) in non-insulin-dependent diabetics patients from both sex in the region of Araraquaraen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationDepartamento de Analises Clinicas Faculdade de Ciencias Farmaceuticas UNESP, 14801-902 - Araraquara, SP-
dc.description.affiliationUnespDepartamento de Analises Clinicas Faculdade de Ciencias Farmaceuticas UNESP, 14801-902 - Araraquara, SP-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofRevista de Ciencias Farmaceuticas-
dc.identifier.scopus2-s2.0-0027763909-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.